Matthew Hamilton

All filings by Matthew Hamilton on record concern Veritas Pharma Inc. In total, 5 filings cover trades dated from 8 August 2016 to 23 February 2017.

In open-market terms, that means 1 purchase worth €12k on one side and 3 sales worth €64k on the other. On balance, insiders were net sellers of €52k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2017: no purchases and 2 sales on the market.

The record was last updated on 27 February 2017 with an open-market sale (€18k) in Veritas Pharma Inc. The last purchase on record was published on 22 November 2016, which is 3,626 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEDI disclosures alone and does not predict where the share price will go.